Torthaí cuardaigh - David J. Pinato
- 1 - 20 toradh as 115 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association? de réir Nadiya Hussain, Muntaha Naeem, David J. Pinato
Foilsithe / Cruthaithe 2020Revisão -
2
-
3
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma de réir Chandan Sanghera, Jhia Jiat Teh, David J. Pinato
Foilsithe / Cruthaithe 2019Revisão -
4
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy de réir Matthias Pinter, David J. Pinato, Pierluigi Ramadori, Mathias Heikenwälder
Foilsithe / Cruthaithe 2022Revisão -
5
Hepatocellular carcinoma de réir David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower
Foilsithe / Cruthaithe 2017Revisão -
6
Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma de réir Philip J. Johnson, David J. Pinato, Anton Kalyuzhnyy, Hidenori Toyoda
Foilsithe / Cruthaithe 2022Artigo -
7
PD-L1 de réir Anthousa Kythreotou, Abdul Siddique, Francesco Mauri, Mark Bower, David J. Pinato
Foilsithe / Cruthaithe 2017Revisão -
8
Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma de réir Michael Flynn, Anwar A. Sayed, Rohini Sharma, Abdul Siddique, David J. Pinato
Foilsithe / Cruthaithe 2018Revisão -
9
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma de réir David J. Pinato, Francesco Mauri, Rathi Ramakrishnan, Lutful Wahab, Tyler Lloyd, Rohini Sharma
Foilsithe / Cruthaithe 2012Artigo -
10
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy de réir Leila Motedayеn Aval, James E. Pease, Rohini Sharma, David J. Pinato
Foilsithe / Cruthaithe 2020Revisão -
11
-
12
-
13
-
14
-
15
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future de réir Amit G. Singal, Mark Yarchoan, Adam C. Yopp, Gonzalo Sapisochín, David J. Pinato, Anjana Pillai
Foilsithe / Cruthaithe 2024Revisão -
16
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior de réir David J. Pinato, James R. Black, Sebastian Trousil, Roberto Dina, Pritesh Trivedi, Francesco Mauri, Rohini Sharma
Foilsithe / Cruthaithe 2017Artigo -
17
Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis de réir Dariusz Lachowski, Ernesto Cortés, Alistair Rice, David J. Pinato, Krista Rombouts, Armando E. del Río Hernández
Foilsithe / Cruthaithe 2019Artigo -
18
Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review de réir Peter R. Galle, Richard S. Finn, Catherine Mitchell, Kerigo Ndirangu, Zahra Ramji, Gabrielle Redhead, David J. Pinato
Foilsithe / Cruthaithe 2024Revisão -
19
Immunotherapy in Hepatocellular Carcinoma de réir Claudia Angela Maria Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato
Foilsithe / Cruthaithe 2021Revisão -
20
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Cancer
Oncology
Hepatocellular carcinoma
Immunotherapy
Biology
Gastroenterology
Cancer research
Immunology
Chemotherapy
Adverse effect
Cohort
Disease
Biochemistry
Liver cancer
Pathology
Sorafenib
Confidence interval
Immune system
Nivolumab
Paleontology
Clinical trial
Hazard ratio
Atezolizumab
Bevacizumab
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Lung cancer
Retrospective cohort study